GLP1R and neurodegenerative disease: Indeed, our finding that GLP-1R agonist treatment reduces the expression of ageing- and neurodegenerative disease-associated transcripts in microglia, which has been reported to express GLP-1R28, suggests that modulation of microglia-dependent neuroinflammatory pathways is an important effect of GLP-1R agonists.